|
MID2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.394580E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.605400E-04 |
| Normal-vs-Stage2 |
3.140600E-01 |
| Normal-vs-Stage3 |
2.33469999999514E-05 |
| Normal-vs-Stage4 |
4.10499999999869E-05 |
| Stage1-vs-Stage2 |
3.929500E-02 |
| Stage1-vs-Stage3 |
1.963570E-01 |
| Stage1-vs-Stage4 |
1.636560E-01 |
| Stage2-vs-Stage3 |
7.177900E-03 |
| Stage2-vs-Stage4 |
8.422900E-03 |
| Stage3-vs-Stage4 |
7.001800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.93612999999093E-05 |
| Normal-vs-AfricanAmerican |
1.494210E-01 |
| Normal-vs-Asian |
1.211510E-04 |
| Caucasian-vs-AfricanAmerican |
1.502420E-01 |
| Caucasian-vs-Asian |
6.781800E-01 |
| AfricanAmerican-vs-Asian |
1.026040E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.37600000000593E-05 |
| Normal-vs-Female |
5.013500E-04 |
| Male-vs-Female |
2.116000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.839500E-04 |
| Normal-vs-Age(41-60Yrs) |
3.798500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.076250E-03 |
| Normal-vs-Age(81-100Yrs) |
4.541100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.889000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.866600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.457000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.768000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.445800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.455400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.941290E-03 |
| Classical-VS-Follicular |
3.699600E-01 |
| Classical-VS-Other |
1.788790E-01 |
| Classical-VS-Normal |
6.432100E-04 |
| Tall-VS-Follicular |
1.977340E-03 |
| Tall-VS-Other |
8.451200E-01 |
| Tall-VS-Normal |
3.8362999998931E-07 |
| Follicular-VS-Other |
1.607970E-01 |
| Follicular-VS-Normal |
3.589800E-02 |
| Other-VS-Normal |
6.819200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.441270E-03 |
| Normal-vs-N1 |
1.22609999997358E-06 |
| N0-vs-N1 |
1.807600E-02 |
|
|
